The future of health, and the business of getting there


There’s a Better Flu Shot

The Future of Medicine


Data & Disruption


Special Report

Soaring Health-Care Costs Forced This Family to Choose Who Can Stay Insured

Many otherwise financially sound families face a stark choice when health care premiums shoot wildly higher: Take on debt or opt out of the medical system and hope for the best.

The Business of Drugs

Patients, Profits & Policy


We Are Optimistic for the Business Overall, Says Bayer CEO

Werner Baumann, chief executive officer of Bayer AG, discusses the Monsanto acquisition, the value of the stock, shareholder confidence in the company and the possible sale of the animal health and consumer health divisions. He speaks exclusively on "Bloomberg Markets: European Open." (Source: Bloomberg)

AstraZeneca CEO Says Europe Prices Should Be Higher, U.S. Lower

AstraZeneca CEO on Impact of Midterms on Drug Market

Sanofi China Chair Says Beijing Sending Good Message

Siemens Healthineers Sees Faster Growth in Diagnostics Business

In Case You Missed It